Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia

NCT01588522 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Alopecia

Interventions

DRUG: Compound 31543 Calcitriol 5 μg/mL
DRUG: Compound 31543 Calcitriol 10 μg/mL
DRUG: Compound 31543 Calcitriol 20 μg/mL
DRUG: Compound 31543 Calcitriol 40 μg/mL
DRUG: Compound 31543 Calcitriol 60 ug/mL
DRUG: Compound 31543 Calcitriol 80 μg/mL

Sponsor

BPGbio